# Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

> **NCT01644591** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 49 (actual)

## Conditions studied

- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Malignant Neoplasm in the Brain
- Metastatic Melanoma
- Pathologic Stage IV Cutaneous Melanoma AJCC v8

## Interventions

- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT01644591
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-08-02
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01644591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01644591, "Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01644591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*